Systematic Reviews and Meta-and Pooled Analyses Previous Lung Diseases and Lung Cancer Risk : A Pooled Analysis From the International Lung Cancer Consortium

To clarify the role of previous lung diseases (chronic bronchitis, emphysema, pneumonia, and tuberculosis) in the development of lung cancer, the authors conducted a pooled analysis of studies in the International Lung Cancer Consortium. Seventeen studies including 24,607 cases and 81,829 controls (noncases), mainly conducted in Europe and North America, were included (1984-2011). Using self-reported data on previous diagnoses of lung diseases, the authors derived study-specific effect estimates by means of logistic regression models or Cox proportional hazards models adjusted for age, sex, and cumulative tobacco smoking. Estimates were pooled using random-effects models. Analyses stratified by smoking status and histology were also conducted. A history of emphysema conferred a 2.44-fold increased risk of lung cancer (95% confidence interval (CI): 1.64, 3.62 (16 studies)). A history of chronic bronchitis conferred a relative risk of 1.47 (95% CI: 1.29, 1.68 (13 studies)). Tuberculosis (relative risk = 1.48, 95% CI: 1.17, 1.87 (16 studies)) and pneumonia (relative risk = 1.57, 95% CI: 1.22, 2.01 (12 studies)) were also associated with lung cancer risk. Among never smokers, elevated risks were observed for emphysema, pneumonia, and tuberculosis. These results suggest that previous lung diseases influence lung cancer risk independently of tobacco use and that these diseases are important for assessing individual risk.

[1]  P. Prorok,et al.  Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. , 2011, Journal of the National Cancer Institute.

[2]  Darren R. Brenner,et al.  Previous Lung Diseases and Lung Cancer Risk: A Systematic Review and Meta-Analysis , 2011, PloS one.

[3]  N J Wald,et al.  UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer , 2011, Thorax.

[4]  Christopher I. Amos,et al.  Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5‐A3 genetic locus and lung cancer risk , 2010, Cancer.

[5]  D. Brenner,et al.  Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors , 2010, BMC Cancer.

[6]  J. Cunningham,et al.  A Rigorous and Comprehensive Validation: Common Genetic Variations and Lung Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[7]  C. Amos,et al.  Racial Differences in the Association Between SNPs on 15q25.1, Smoking Behavior, and Risk of Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  Erika Avila-Tang,et al.  Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors , 2009, Clinical Cancer Research.

[9]  M. Karagas,et al.  Lung Cancer in a U.S. Population with Low to Moderate Arsenic Exposure , 2009, Environmental health perspectives.

[10]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[11]  G. Gamble,et al.  Lung Cancer Susceptibility Model Based on Age, Family History and Genetic Variants , 2009, PloS one.

[12]  E. Szabo,et al.  Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. , 2009, Journal of the National Cancer Institute.

[13]  A. Schwartz,et al.  Chronic Obstructive Lung Diseases and Risk of Non-small Cell Lung Cancer in Women , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  P. Metcalf,et al.  COPD prevalence is increased in lung cancer, independent of age, sex and smoking history , 2009, European Respiratory Journal.

[15]  M. Radeos,et al.  Validation of self-reported chronic obstructive pulmonary disease among patients in the ED. , 2009, The American journal of emergency medicine.

[16]  Ross J. Harris,et al.  Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis , 2009, Cancer Causes & Control.

[17]  P. Jani,et al.  Inflammatory mechanisms in the lung , 2008, Journal of inflammation research.

[18]  Paolo Vineis,et al.  International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. , 2008, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  Ugolini Donatella,et al.  The CREST Biorepository: A Tool for Molecular Epidemiology and Translational Studies on Malignant Mesothelioma, Lung Cancer, and Other Respiratory Tract Diseases , 2008, Cancer Epidemiology Biomarkers & Prevention.

[20]  J. Leader,et al.  Association of radiographic emphysema and airflow obstruction with lung cancer. , 2008, American journal of respiratory and critical care medicine.

[21]  M. Spitz,et al.  An Expanded Risk Prediction Model for Lung Cancer , 2008, Cancer Prevention Research.

[22]  C. Begg,et al.  DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  H. Morgenstern,et al.  Dietary flavonoid intake and lung cancer—A population‐based case‐control study , 2008, Cancer.

[24]  Florian Kronenberg,et al.  Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[25]  E. Engels.  Inflammation in the development of lung cancer: epidemiological evidence , 2008, Expert review of anticancer therapy.

[26]  Y. Rojanasakul,et al.  Inflammation and Lung Cancer: Roles of Reactive Oxygen/Nitrogen Species , 2008, Journal of toxicology and environmental health. Part B, Critical reviews.

[27]  S. Duffy,et al.  The LLP risk model: an individual risk prediction model for lung cancer , 2007, British Journal of Cancer.

[28]  Gorka Bastarrika,et al.  Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. , 2007, Chest.

[29]  J. Reardon.  Environmental tobacco smoke: respiratory and other health effects. , 2007, Clinics in chest medicine.

[30]  A. Tjønneland,et al.  Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: A population-based prospective cohort study of 57,053 men and women in Denmark , 2007, Scandinavian journal of public health.

[31]  M. J. Hall,et al.  2005 National Hospital Discharge Survey. , 2007, Advance data.

[32]  Wan-Wan Lin,et al.  A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.

[33]  A. N. Hicks,et al.  The UDP-Glucuronosyltransferase 2B17 Gene Deletion Polymorphism: Sex-Specific Association with Urinary 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Glucuronidation Phenotype and Risk for Lung Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[34]  K. Straif,et al.  Lung cancer risk and workplace exposure to environmental tobacco smoke. , 2007, American journal of public health.

[35]  P. Brennan,et al.  Occupational Exposure to Crystalline Silica and Risk of Lung Cancer: A Multicenter Case–Control Study in Europe , 2007, Epidemiology.

[36]  P. Brennan,et al.  High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe. , 2006, American journal of epidemiology.

[37]  Avrum Spira,et al.  State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. , 2006, Proceedings of the American Thoracic Society.

[38]  S. Duffy,et al.  The Liverpool Lung Project research protocol. , 2005, International journal of oncology.

[39]  R. Peek,et al.  Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. , 2005, Cancer research.

[40]  A. Lindberg,et al.  Prevalence of Chronic Obstructive Pulmonary Disease according to BTS, ERS, GOLD and ATS Criteria in Relation to Doctor’s Diagnosis, Symptoms, Age, Gender, and Smoking Habits , 2005, Respiration.

[41]  R Holle,et al.  KORA - A Research Platform for Population Based Health Research , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[42]  Daniel Krewski,et al.  Residential Radon and Risk of Lung Cancer: A Combined Analysis of 7 North American Case-Control Studies , 2005, Epidemiology.

[43]  W. Bamlet,et al.  Glutathione pathway genes and lung cancer risk in young and old populations. , 2004, Carcinogenesis.

[44]  R. A. Robinson,et al.  Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review. , 2004, Journal of the National Cancer Institute.

[45]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[46]  H. Wichmann,et al.  Residential Radon and Risk of Lung Cancer in Eastern Germany , 2003, Epidemiology.

[47]  J. Mulshine,et al.  The potential contributions of chronic inflammation to lung carcinogenesis. , 2003, Clinical lung cancer.

[48]  F. Speizer,et al.  Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. , 2002, American journal of epidemiology.

[49]  O. Ramilo,et al.  Mycoplasma pneumoniae Induces Chronic Respiratory Infection, Airway Hyperreactivity, and Pulmonary Inflammation: a Murine Model of Infection-Associated Chronic Reactive Airway Disease , 2002, Infection and Immunity.

[50]  F. Fitzpatrick,et al.  Inflammation, carcinogenesis and cancer. , 2001, International immunopharmacology.

[51]  O. Ramilo,et al.  Elevated Cytokine and Chemokine Levels and Prolonged Pulmonary Airflow Resistance in a Murine Mycoplasma pneumoniaePneumonia Model: a Microbiologic, Histologic, Immunologic, and Respiratory Plethysmographic Profile , 2001, Infection and Immunity.

[52]  P C Prorok,et al.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.

[53]  N. Rothman,et al.  Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[54]  D. Postma,et al.  Ongoing airway inflammation in patients with COPD who do not currently smoke. , 2000, Thorax.

[55]  L. Kolonel,et al.  Intake of Flavonoids and Lung Cancer. , 2000, Journal of the National Cancer Institute.

[56]  Dirkje S Postma,et al.  Ongoing airway inflammation in patients with COPD who do not currently smoke , 1999, Chest.

[57]  J. Moulin,et al.  A meta-analysis of epidemiologic studies of lung cancer in welders. , 1997, Scandinavian journal of work, environment & health.

[58]  E. Wynder,et al.  Insulation, asbestos, smoking habits, and lung cancer cell types. , 1995, American journal of industrial medicine.

[59]  S. Weitzman,et al.  Inflammation and cancer: role of phagocyte-generated oxidants in , 2011 .

[60]  J M Robins,et al.  Conceptual problems in the definition and interpretation of attributable fractions. , 1988, American journal of epidemiology.

[61]  Rex Galbraith,et al.  Graphical display of estimates having differing standard errors , 1988 .

[62]  D. Lynch,et al.  The National Lung Screening Trial: overview and study design. , 2011, Radiology.

[63]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[64]  R. Medzhitov,et al.  Toll-like receptors and cancer , 2009, Nature Reviews Cancer.

[65]  K. Ahn,et al.  Association between haplotypes of manganese superoxide dismutase (SOD2), smoking, and lung cancer risk. , 2009, Free radical biology & medicine.

[66]  B. Parodi,et al.  The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases. , 2008, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[67]  C. Mathers.  Global Burden of Disease , 2008 .

[68]  J. Brody,et al.  Chronic obstructive pulmonary disease, inflammation, and lung cancer , 2006 .

[69]  K. Kelsey,et al.  CYP1A1 variants and smoking‐related lung cancer in San Francisco bay area Latinos and African Americans , 2005, International journal of cancer.

[70]  H. Wichmann,et al.  Case-control study on lung cancer and residential radon in western Germany. , 2001, American journal of epidemiology.

[71]  E. Graves.  National Hospital Discharge Survey. , 1989, Vital and health statistics. Series 13, Data from the National Health Survey.

[72]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[73]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[74]  Références , 2022, Revue annuelle du marché des produits forestiers 2019-2020.